Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder

BACKGROUND: Treatment of neuromyelitis optica spectrum disorder (NMOSD) has so far been based on retrospective case series. The results of six randomized clinical trials including five different monoclonal antibodies targeting four molecules and three distinct pathophysiological pathways have recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Holmøy, Trygve, Høglund, Rune Alexander, Illes, Zsolt, Myhr, Kjell-Morten, Torkildsen, Øivind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563615/
https://www.ncbi.nlm.nih.gov/pubmed/33011853
http://dx.doi.org/10.1007/s00415-020-10235-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563615/
https://www.ncbi.nlm.nih.gov/pubmed/33011853
http://dx.doi.org/10.1007/s00415-020-10235-5

Ejemplares similares